{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:04:51Z","timestamp":1761059091497},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T00:00:00Z","timestamp":1281571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1756-9966-29-111","type":"journal-article","created":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T18:15:34Z","timestamp":1282673734000},"source":"Crossref","is-referenced-by-count":10,"title":["GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies"],"prefix":"10.1186","volume":"29","author":[{"given":"Zhen","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-ming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run-bi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gao-fei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,12]]},"reference":[{"key":"358_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35010517","volume":"2","author":"DJ Sieg","year":"2000","unstructured":"Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD: FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol. 2000, 2: 249-256. 10.1038\/35010517.","journal-title":"Nat Cell Biol"},{"key":"358_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10555-008-9165-4","volume":"28","author":"J Zhao","year":"2009","unstructured":"Zhao J, Guan JL: Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 2009, 28: 35-49. 10.1007\/s10555-008-9165-4.","journal-title":"Cancer Metastasis Rev"},{"key":"358_CR3","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1158\/0008-5472.CAN-03-3005","volume":"64","author":"C Recher","year":"2004","unstructured":"Recher C, Ysebaert L, Beyne-Rauzy O, Mansat-De Mas V, Ruidavets JB, Cariven P, Demur C, Payrastre B, Laurent G, Racaud-Sultan C: Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res. 2004, 64: 3191-3197. 10.1158\/0008-5472.CAN-03-3005.","journal-title":"Cancer Res"},{"key":"358_CR4","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.leukres.2008.10.014","volume":"33","author":"E Tavernier-Tardy","year":"2009","unstructured":"Tavernier-Tardy E, Cornillon J, Campos L, Flandrin P, Duval A, Nadal N, Guyotat D: Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia. Leuk Res. 2009, 33: 764-768. 10.1016\/j.leukres.2008.10.014.","journal-title":"Leuk Res"},{"key":"358_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/ajh.21381","volume":"84","author":"Y Le","year":"2009","unstructured":"Le Y, Xu L, Lu J, Fang J, Nardi V, Chai L, Silberstein LE: FAK silencing inhibits leukemogenesis in BCR\/ABL-transformed hematopoietic cells. Am J Hematol. 2009, 84: 273-278. 10.1002\/ajh.21381.","journal-title":"Am J Hematol"},{"key":"358_CR6","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1182\/blood-2007-06-097253","volume":"111","author":"JW Tyner","year":"2008","unstructured":"Tyner JW, Walters DK, Willis SG, Luttropp M, Oost J, Loriaux M, Erickson H, Corbin AS, O'Hare T, Heinrich MC, Deininger MW, Druker BJ: RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia. Blood. 2008, 111: 2238-2245. 10.1182\/blood-2007-06-097253.","journal-title":"Blood"},{"key":"358_CR7","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1128\/MCB.16.6.3169","volume":"6","author":"JD Hildebrand","year":"1996","unstructured":"Hildebrand JD, Taylor JM, Parsons JT: An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol Cell Biol. 1996, 6: 3169-3178.","journal-title":"Mol Cell Biol"},{"key":"358_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/emboj\/20.4.755","volume":"20","author":"E Sahai","year":"2001","unstructured":"Sahai E, Olson MF, Marshall CJ: Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 2001, 20: 755-766. 10.1093\/emboj\/20.4.755.","journal-title":"EMBO J"},{"key":"358_CR9","doi-asserted-by":"publisher","first-page":"9168","DOI":"10.1073\/pnas.150079597","volume":"97","author":"A Borkhardt","year":"2000","unstructured":"Borkhardt A, Bojesen S, Haas OA, Fuchs U, Bartelheimer D, Loncarevic IF, Bohle RM, Harbott J, Repp R, Jaeger U, Viehmann S, Henn T, Korth P, Scharr D, Lampert F: The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome\/acute myeloid leukemia with a deletion 5q. Proc Natl Acad Sci USA. 2000, 97: 9168-9173. 10.1073\/pnas.150079597.","journal-title":"Proc Natl Acad Sci USA"},{"key":"358_CR10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/sj.bjc.6602939","volume":"94","author":"SE Bojesen","year":"2006","unstructured":"Bojesen SE, Ammerpohl O, Weinh\u00e4usl A, Haas OA, Mettal H, Bohle RM, Borkhardt A, Fuchs U: Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome. Br J Cancer. 2006, 94: 323-332. 10.1038\/sj.bjc.6602939.","journal-title":"Br J Cancer"},{"key":"358_CR11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","volume":"103","author":"JM Bennett","year":"1985","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French-American-British Cooperative Group. Ann Intern Med. 1985, 103: 620-625.","journal-title":"Ann Intern Med"},{"key":"358_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982, 51: 189-199.","journal-title":"Br J Haematol"},{"key":"358_CR13","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD: The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002, 100: 2292-2302. 10.1182\/blood-2002-04-1199.","journal-title":"Blood"},{"key":"358_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0609.1995.tb00225.x","volume":"55","author":"F Lo Coco","year":"1995","unstructured":"Lo Coco F, Foa R: Diagnostic and prognostic advances in the immunophenotypic and genetic characterization of acute leukaemia. Eur J Haematol. 1995, 55: 1-9. 10.1111\/j.1600-0609.1995.tb00225.x.","journal-title":"Eur J Haematol"},{"key":"358_CR15","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","volume":"96","author":"ML Slovak","year":"2000","unstructured":"Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR: Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study. Blood. 2000, 96: 4075-4083.","journal-title":"Blood"},{"key":"358_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1600-0609.2008.01178.x","volume":"82","author":"J Qian","year":"2009","unstructured":"Qian J, Wang YL, Lin J, Yao DM, Xu WR, Wu CY: Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia. Eur J Haematol. 2009, 82: 119-123. 10.1111\/j.1600-0609.2008.01178.x.","journal-title":"Eur J Haematol"},{"key":"358_CR17","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J: International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997, 89: 2079-2088.","journal-title":"Blood"},{"key":"358_CR18","first-page":"91","volume":"1796","author":"R Karlsson","year":"2009","unstructured":"Karlsson R, Pedersen ED, Wang Z, Brakebusch C: Rho GTPase function in tumorigenesis. Biochim Biophys Acta. 2009, 1796: 91-98.","journal-title":"Biochim Biophys Acta"},{"key":"358_CR19","first-page":"121","volume":"1705","author":"SA Benitah","year":"2004","unstructured":"Benitah SA, Valer\u00f3n PF, van Aelst L, Marshall CJ, Lacal JC: Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochim Biophys Acta. 2004, 1705: 121-132.","journal-title":"Biochim Biophys Acta"},{"key":"358_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2003.08.035","volume":"206","author":"S Aznar","year":"2004","unstructured":"Aznar S, Fern\u00e1ndez-Valer\u00f3n P, Espina C, Lacal JC: Rho GTPases: potential candidates for anticancer therapy. Cancer Lett. 2004, 206: 181-191. 10.1016\/j.canlet.2003.08.035.","journal-title":"Cancer Lett"},{"key":"358_CR21","doi-asserted-by":"publisher","first-page":"16433","DOI":"10.1074\/jbc.M112090200","volume":"277","author":"A Vidal","year":"2002","unstructured":"Vidal A, Millard SS, Miller JP, Koff A: Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J Biol Chem. 2002, 277: 16433-16440. 10.1074\/jbc.M112090200.","journal-title":"J Biol Chem"},{"key":"358_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/hh1801.096337","volume":"89","author":"TM Seasholtz","year":"2001","unstructured":"Seasholtz TM, Zhang T, Morissette MR, Howes AL, Yang AH, Brown JH: Increased expression and activity of RhoA are associated with increased DNA synthesis and reduced p27(Kip1) expression in the vasculature of hypertensive rats. Circ Res. 2001, 89: 488-495. 10.1161\/hh1801.096337.","journal-title":"Circ Res"},{"key":"358_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/28425","volume":"394","author":"MF Olson","year":"1998","unstructured":"Olson MF, Paterson HF, Marshall CJ: Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1\/Cip1. Nature. 1998, 394: 295-299. 10.1038\/28425.","journal-title":"Nature"},{"key":"358_CR24","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/sj.onc.1205242","volume":"21","author":"M Liberto","year":"2002","unstructured":"Liberto M, Cobrinik D, Minden A: Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene. 2002, 21: 1590-1599. 10.1038\/sj.onc.1205242.","journal-title":"Oncogene"},{"key":"358_CR25","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/j.febslet.2008.04.039","volume":"582","author":"FM Vega","year":"2008","unstructured":"Vega FM, Ridley AJ: Rho GTPases in cancer cell biology. FEBS Lett. 2008, 582: 2093-2101. 10.1016\/j.febslet.2008.04.039.","journal-title":"FEBS Lett"},{"key":"358_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ: Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer. 2007, 7: 441-453. 10.1038\/nrc2147.","journal-title":"Nat Rev Cancer"},{"key":"358_CR27","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1182\/blood-2003-12-4111","volume":"103","author":"B Calabretta","year":"2004","unstructured":"Calabretta B, Perrotti D: The biology of CML blast crisis. Blood. 2004, 103: 4010-4022. 10.1182\/blood-2003-12-4111.","journal-title":"Blood"},{"key":"358_CR28","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/sj.onc.1210841","volume":"27","author":"S Sahay","year":"2008","unstructured":"Sahay S, Pannucci NL, Mahon GM, Rodriguez PL, Megjugorac NJ, Kostenko EV, Ozer HL, Whitehead IP: The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation. Oncogene. 2008, 27: 2064-2071. 10.1038\/sj.onc.1210841.","journal-title":"Oncogene"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-29-111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-9966-29-111\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-29-111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T22:04:10Z","timestamp":1591826650000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-29-111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["358"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-29-111","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,12]]},"article-number":"111"}}